[1]
Aisha Alyassi et al. 2024. META-ANALYSIS OF CARDIOPROTECTIVE EFFECTS OF COMBINED SGLT2 INHIBITORS AND GLP-1 RECEPTOR AGONISTS VS. MONOTHERAPY IN PATIENTS WITH TYPE 2 DIABETES AND HEART FAILURE: IMPACT ON MORTALITY AND HOSPITALIZATION OUTCOMES. Insights-Journal of Health and Rehabilitation . 2, 2 (Health & Rehab) (Nov. 2024), 176–186. DOI:https://doi.org/10.71000/ijhr139.